Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Migraine Disorders | 27 | 2022 | 1411 | 5.060 |
Why?
|
| Headache | 17 | 2022 | 1109 | 4.710 |
Why?
|
| Headache Disorders, Secondary | 8 | 2022 | 32 | 4.050 |
Why?
|
| Migraine without Aura | 4 | 2022 | 71 | 2.520 |
Why?
|
| Headache Disorders | 6 | 2022 | 128 | 2.150 |
Why?
|
| Analgesics | 8 | 2021 | 1008 | 1.600 |
Why?
|
| Botulinum Toxins, Type A | 3 | 2022 | 197 | 1.540 |
Why?
|
| Facial Pain | 2 | 2018 | 124 | 1.290 |
Why?
|
| Nonprescription Drugs | 2 | 2013 | 116 | 0.880 |
Why?
|
| Cluster Headache | 3 | 2017 | 44 | 0.820 |
Why?
|
| Oxymetazoline | 1 | 2020 | 5 | 0.800 |
Why?
|
| Tetracaine | 1 | 2020 | 32 | 0.790 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2020 | 176 | 0.730 |
Why?
|
| Amitriptyline | 2 | 2016 | 112 | 0.720 |
Why?
|
| Neuromuscular Agents | 1 | 2020 | 138 | 0.690 |
Why?
|
| Neurology | 2 | 2017 | 732 | 0.670 |
Why?
|
| Fellowships and Scholarships | 2 | 2017 | 978 | 0.660 |
Why?
|
| Clinical Protocols | 2 | 2021 | 1470 | 0.640 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2018 | 392 | 0.610 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2018 | 147 | 0.600 |
Why?
|
| Catastrophization | 1 | 2019 | 315 | 0.570 |
Why?
|
| Pituitary Diseases | 1 | 2016 | 132 | 0.560 |
Why?
|
| Anesthetics, Local | 2 | 2020 | 988 | 0.550 |
Why?
|
| Spinal Nerves | 1 | 2014 | 88 | 0.520 |
Why?
|
| Facial Nerve Diseases | 1 | 2014 | 52 | 0.520 |
Why?
|
| Physicians | 3 | 2021 | 4292 | 0.500 |
Why?
|
| Internationality | 1 | 2019 | 1002 | 0.480 |
Why?
|
| Pain Measurement | 3 | 2021 | 3510 | 0.480 |
Why?
|
| Drug Tolerance | 2 | 2011 | 397 | 0.470 |
Why?
|
| Neuralgia | 1 | 2018 | 514 | 0.470 |
Why?
|
| Patient Care | 1 | 2018 | 610 | 0.450 |
Why?
|
| Epidural Space | 1 | 2013 | 134 | 0.440 |
Why?
|
| Injections, Epidural | 1 | 2013 | 191 | 0.420 |
Why?
|
| Spinal Puncture | 1 | 2013 | 284 | 0.410 |
Why?
|
| Primary Prevention | 1 | 2018 | 1134 | 0.410 |
Why?
|
| Drug Therapy | 1 | 2013 | 518 | 0.400 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 3376 | 0.390 |
Why?
|
| Learning | 1 | 2019 | 1596 | 0.380 |
Why?
|
| Telemedicine | 3 | 2021 | 2583 | 0.380 |
Why?
|
| Guideline Adherence | 1 | 2020 | 2315 | 0.360 |
Why?
|
| Italy | 2 | 2021 | 744 | 0.360 |
Why?
|
| Neurosurgery | 1 | 2015 | 635 | 0.360 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7487 | 0.350 |
Why?
|
| Epilepsy | 2 | 2022 | 2892 | 0.350 |
Why?
|
| Philosophy | 1 | 2008 | 64 | 0.340 |
Why?
|
| Nerve Block | 1 | 2014 | 637 | 0.330 |
Why?
|
| Tension-Type Headache | 1 | 2008 | 55 | 0.320 |
Why?
|
| Catheterization | 1 | 2013 | 1463 | 0.320 |
Why?
|
| Humans | 60 | 2022 | 708843 | 0.310 |
Why?
|
| Tryptamines | 2 | 2018 | 86 | 0.280 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 2 | 2017 | 45 | 0.280 |
Why?
|
| Cost of Illness | 3 | 2020 | 1820 | 0.260 |
Why?
|
| Pain | 1 | 2019 | 4636 | 0.250 |
Why?
|
| Pandemics | 1 | 2021 | 7089 | 0.210 |
Why?
|
| Electronic Health Records | 3 | 2018 | 4173 | 0.210 |
Why?
|
| Treatment Outcome | 8 | 2021 | 61932 | 0.210 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2022 | 272 | 0.200 |
Why?
|
| Meditation | 1 | 2021 | 231 | 0.180 |
Why?
|
| Serotonin Syndrome | 1 | 2018 | 17 | 0.180 |
Why?
|
| Administration, Intranasal | 1 | 2020 | 444 | 0.180 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2019 | 158 | 0.170 |
Why?
|
| Bell Palsy | 1 | 2018 | 43 | 0.170 |
Why?
|
| Pain Clinics | 1 | 2016 | 55 | 0.160 |
Why?
|
| Attitude of Health Personnel | 2 | 2021 | 3885 | 0.150 |
Why?
|
| Adolescent | 7 | 2022 | 84718 | 0.150 |
Why?
|
| Antidepressive Agents | 2 | 2018 | 2813 | 0.140 |
Why?
|
| Health Care Surveys | 2 | 2020 | 2502 | 0.140 |
Why?
|
| History, 20th Century | 2 | 2015 | 2837 | 0.140 |
Why?
|
| Drug Combinations | 1 | 2020 | 1925 | 0.130 |
Why?
|
| RNA, Viral | 1 | 2022 | 2847 | 0.130 |
Why?
|
| Censuses | 1 | 2014 | 184 | 0.120 |
Why?
|
| False Positive Reactions | 1 | 2016 | 1004 | 0.120 |
Why?
|
| Anxiety | 4 | 2021 | 3887 | 0.120 |
Why?
|
| Benzamides | 1 | 2019 | 1406 | 0.120 |
Why?
|
| Middle Aged | 13 | 2021 | 213752 | 0.120 |
Why?
|
| Face | 1 | 2018 | 973 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2022 | 4883 | 0.110 |
Why?
|
| Diagnostic Errors | 2 | 2017 | 1260 | 0.110 |
Why?
|
| Sumatriptan | 1 | 2012 | 63 | 0.110 |
Why?
|
| Health Surveys | 2 | 2020 | 3994 | 0.110 |
Why?
|
| Piperidines | 1 | 2019 | 1582 | 0.100 |
Why?
|
| Adult | 17 | 2021 | 211041 | 0.100 |
Why?
|
| Female | 20 | 2021 | 375205 | 0.100 |
Why?
|
| Bupivacaine | 1 | 2014 | 424 | 0.100 |
Why?
|
| Sternocostal Joints | 1 | 1989 | 3 | 0.100 |
Why?
|
| Patient Education as Topic | 2 | 2013 | 2340 | 0.100 |
Why?
|
| Sternoclavicular Joint | 1 | 1989 | 30 | 0.100 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2018 | 1419 | 0.100 |
Why?
|
| Paratyphoid Fever | 1 | 1989 | 32 | 0.100 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2012 | 441 | 0.090 |
Why?
|
| Demography | 1 | 2014 | 1596 | 0.090 |
Why?
|
| Medicine | 1 | 2017 | 851 | 0.090 |
Why?
|
| Phytotherapy | 1 | 2012 | 307 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1711 | 0.090 |
Why?
|
| Internet | 1 | 2021 | 3074 | 0.090 |
Why?
|
| Yoga | 1 | 2012 | 222 | 0.090 |
Why?
|
| Forecasting | 1 | 2018 | 2941 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2015 | 1569 | 0.090 |
Why?
|
| Prevalence | 4 | 2020 | 14712 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2018 | 1840 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 1446 | 0.080 |
Why?
|
| Young Adult | 4 | 2020 | 55940 | 0.080 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1989 | 268 | 0.080 |
Why?
|
| Pyridines | 1 | 2019 | 2862 | 0.080 |
Why?
|
| Happiness | 1 | 2008 | 171 | 0.080 |
Why?
|
| Craniopharyngioma | 1 | 1989 | 278 | 0.080 |
Why?
|
| Male | 15 | 2021 | 349524 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2017 | 2606 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 14836 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2014 | 2524 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2779 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 8024 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 9584 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2020 | 8992 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2011 | 1505 | 0.070 |
Why?
|
| Child | 3 | 2022 | 73636 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 13274 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 11239 | 0.060 |
Why?
|
| Registries | 2 | 2017 | 7989 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 13536 | 0.060 |
Why?
|
| Menstrual Cycle | 1 | 2007 | 531 | 0.060 |
Why?
|
| United States | 5 | 2021 | 67165 | 0.060 |
Why?
|
| Boston | 1 | 2016 | 9402 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2011 | 1040 | 0.060 |
Why?
|
| Osteoarthritis | 1 | 1989 | 960 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2244 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 1224 | 0.060 |
Why?
|
| Quality of Life | 1 | 2022 | 11594 | 0.050 |
Why?
|
| Curriculum | 1 | 2014 | 3329 | 0.050 |
Why?
|
| Tuberculosis, Lymph Node | 1 | 1980 | 22 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2016 | 7763 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2013 | 5918 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39038 | 0.050 |
Why?
|
| Estrogens | 1 | 2007 | 1511 | 0.050 |
Why?
|
| Counseling | 1 | 2008 | 1504 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 2277 | 0.050 |
Why?
|
| Menopause | 1 | 2007 | 1518 | 0.040 |
Why?
|
| Aged | 5 | 2019 | 161488 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 41038 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 19423 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2021 | 7994 | 0.040 |
Why?
|
| Vertigo | 1 | 2019 | 192 | 0.040 |
Why?
|
| Mediastinal Neoplasms | 1 | 1980 | 442 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 39292 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 3308 | 0.040 |
Why?
|
| Life Style | 1 | 2008 | 3636 | 0.040 |
Why?
|
| Radicular Cyst | 1 | 1995 | 13 | 0.040 |
Why?
|
| Prescriptions | 1 | 2018 | 335 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 4293 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2008 | 3436 | 0.030 |
Why?
|
| Disease Progression | 1 | 2011 | 13298 | 0.030 |
Why?
|
| Maxillary Sinus | 1 | 1995 | 175 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2018 | 615 | 0.030 |
Why?
|
| Diet | 1 | 2012 | 7392 | 0.030 |
Why?
|
| Fatigue | 1 | 2019 | 1450 | 0.030 |
Why?
|
| Social Behavior | 1 | 2018 | 1108 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 3944 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2018 | 2571 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2018 | 71483 | 0.020 |
Why?
|
| Salmonella paratyphi A | 1 | 1989 | 39 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2018 | 2506 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2021 | 3776 | 0.020 |
Why?
|
| Joints | 1 | 1989 | 334 | 0.020 |
Why?
|
| Phytoestrogens | 1 | 2007 | 55 | 0.020 |
Why?
|
| Prognosis | 1 | 2008 | 28919 | 0.020 |
Why?
|
| Shoulder | 1 | 1988 | 249 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8255 | 0.020 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2007 | 177 | 0.020 |
Why?
|
| Retreatment | 1 | 2007 | 628 | 0.020 |
Why?
|
| Television | 1 | 1988 | 410 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2019 | 11877 | 0.020 |
Why?
|
| Cysts | 1 | 1989 | 630 | 0.020 |
Why?
|
| Depression | 2 | 2018 | 7202 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 17218 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2007 | 360 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 10339 | 0.010 |
Why?
|
| Ovary | 1 | 2007 | 997 | 0.010 |
Why?
|
| Calcinosis | 1 | 1989 | 1435 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 69553 | 0.010 |
Why?
|
| Electric Stimulation Therapy | 1 | 2007 | 624 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2007 | 2680 | 0.010 |
Why?
|
| Smoking | 1 | 2017 | 8612 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2007 | 1178 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 3 | 1995 | 20308 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2017 | 6395 | 0.010 |
Why?
|
| Maxillary Sinusitis | 1 | 1995 | 36 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2007 | 2020 | 0.010 |
Why?
|
| Drainage | 1 | 1980 | 1131 | 0.010 |
Why?
|
| Reference Values | 1 | 1981 | 5041 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 170486 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 1980 | 1294 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1989 | 5044 | 0.010 |
Why?
|
| Plasmacytoma | 1 | 1989 | 184 | 0.010 |
Why?
|
| Hypertension | 1 | 2008 | 8161 | 0.010 |
Why?
|
| Radiography | 2 | 1989 | 6989 | 0.010 |
Why?
|
| Sex Factors | 1 | 1981 | 10566 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1981 | 5781 | 0.000 |
Why?
|
| Age Factors | 1 | 1981 | 18712 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1989 | 34151 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1989 | 19800 | 0.000 |
Why?
|
Concepts
(200)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_